Vext Cannabis Co.'s Q2 Revenue Drops Over 8% YoY, But Top Cannabis Analyst Sees Ohio Market As Major Growth Driver
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 20 2024
0mins
Source: Benzinga
Financial Performance: Vext Science, Inc. reported a decline in revenue from $9.2 million to $8.4 million year-over-year for Q2 2024, with a net loss of $4.4 million compared to a profit of $535,454 in the same quarter last year.
Market Expansion: The company is poised to benefit from the launch of recreational cannabis sales in Ohio, having secured necessary licenses and expressing optimism about future growth opportunities in both Ohio and Arizona.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
